Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharma-Bio Serv (PBSV) Tax Provisions (2016 - 2026)

Pharma-Bio Serv (PBSV) has disclosed Tax Provisions for 15 consecutive years, with $4356.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Tax Provisions rose 114.07% year-over-year to $4356.0, compared with a TTM value of $6203.0 through Oct 2025, down 72.02%, and an annual FY2025 reading of $6203.0, down 72.02% over the prior year.
  • Tax Provisions was $4356.0 for Q4 2025 at Pharma-Bio Serv, up from -$4779.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $168040.0 in Q2 2023 and bottomed at -$30960.0 in Q4 2024.
  • Average Tax Provisions over 5 years is $38774.1, with a median of $24483.5 recorded in 2022.
  • The sharpest move saw Tax Provisions surged 847.64% in 2021, then tumbled 4406.55% in 2024.
  • Year by year, Tax Provisions stood at $75887.0 in 2021, then crashed by 63.38% to $27788.0 in 2022, then tumbled by 102.47% to -$687.0 in 2023, then crashed by 4406.55% to -$30960.0 in 2024, then soared by 114.07% to $4356.0 in 2025.
  • Business Quant data shows Tax Provisions for PBSV at $4356.0 in Q4 2025, -$4779.0 in Q3 2025, and $5511.0 in Q2 2025.